Medicamen Biotech Share Price
Medicamen Biotech Share Price Today
As of 6 Jul 2026, Medicamen Biotech share price is ₹260.05. The stock opened at ₹262.20, compared to its previous close of ₹260.90. During today's trading session, Medicamen Biotech share price moved in the range of ₹258.55 to ₹263.00, with an average price of ₹260.77 for the day. Looking at its last 52-week, the stock has touched a low of ₹212.40 and a high of ₹447.65. On the performance front, Medicamen Biotech share price has declined by 31.22% over the last six months and is down 35.80% on a year-on-year basis.
Medicamen Biotech Returns Calculator
Medicamen Biotech Shareholder Returns
Medicamen Biotech Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,79,471.00 | 69.89 | 10.71 | 15.32% | 0.00 | 19.56% | 629.49 | 0.44% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,61,290.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,820.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Zydus Lifesciences | 1,10,651.00 | 22.41 | 4.23 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.15 | 12.54% | 3.32 | 0.64% | 0.63 | 38.68 |
| Lupin | 1,13,215.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.73% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.93 | 6.41 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 94,095.70 | 26.86 | 2.48 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 83,293.00 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Medicamen Biotech Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹162.55 | ₹179.31 | ₹140.87 | ₹115.45 |
| Other Income | ₹6.24 | ₹2.33 | ₹2.46 | ₹1.72 |
| Total Revenue | ₹168.79 | ₹181.63 | ₹143.33 | ₹117.17 |
| Total Expenses | ₹158.91 | ₹168.56 | ₹126.28 | ₹99.07 |
| Profit Before Tax | ₹9.88 | ₹13.08 | ₹17.05 | ₹18.09 |
| Tax | ₹3.32 | ₹3.58 | ₹2.32 | ₹3.20 |
| Profit After Tax | ₹6.56 | ₹9.49 | ₹14.73 | ₹14.90 |
| EPS - Basic | ₹5.60 | ₹8.63 | ₹11.64 | ₹12.19 |
| EPS - Diluted | ₹5.60 | ₹8.63 | ₹11.64 | ₹12.19 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹6.56 | ₹9.49 | ₹14.73 | ₹14.90 |
| Income before WC changes | ₹19.44 | ₹23.84 | ₹25.61 | ₹25.13 |
| Change in Assets | -₹17.53 | -₹21.45 | -₹29.22 | -₹30.20 |
| Change in Liabilities | -₹8.71 | -₹6.07 | ₹0.44 | ₹12.38 |
| Change in WC | -₹26.25 | -₹27.52 | -₹28.78 | -₹17.82 |
| Cash flow from Operations | -₹8.16 | -₹6.74 | -₹6.29 | ₹4.11 |
| Cash flow from Investing | -₹1.40 | -₹5.56 | -₹5.88 | -₹8.47 |
| Cash flow from Financing | -₹1.47 | ₹6.31 | ₹29.13 | ₹4.30 |
| Total Cash Flow | -₹11.03 | -₹5.99 | ₹16.95 | -₹0.07 |
| Cash (Start of the year) | ₹14.79 | ₹20.78 | ₹3.82 | ₹3.89 |
| Cash (End of the year) | ₹3.76 | ₹14.79 | ₹20.78 | ₹3.82 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹132.60 | ₹134.96 | ₹115.15 | ₹102.66 |
| Current Assets | ₹164.55 | ₹159.59 | ₹163.36 | ₹123.04 |
| Total Assets | ₹297.15 | ₹294.55 | ₹278.52 | ₹225.69 |
| Current Liabilities | ₹78.16 | ₹84.56 | ₹82.57 | ₹72.69 |
| Net Current Asset | ₹86.39 | ₹75.04 | ₹80.79 | ₹50.35 |
| Non-Current Liabilities | ₹5.94 | ₹3.01 | ₹2.53 | ₹6.53 |
| Equity Capital | ₹213.05 | ₹206.98 | ₹193.41 | ₹146.47 |
| Total Equity & Liabilities | ₹297.15 | ₹294.55 | ₹278.52 | ₹225.69 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹151.46 | ₹172.39 | ₹137.88 | ₹115.45 |
| Other Income | ₹6.23 | ₹2.30 | ₹2.46 | ₹1.72 |
| Total Revenue | ₹157.69 | ₹174.69 | ₹140.35 | ₹117.17 |
| Total Expenses | ₹144.91 | ₹157.80 | ₹123.01 | ₹99.06 |
| Profit Before Tax | ₹12.77 | ₹16.89 | ₹17.33 | ₹18.10 |
| Tax | ₹3.33 | ₹3.59 | ₹2.33 | ₹3.20 |
| Profit After Tax | ₹9.45 | ₹13.30 | ₹15.00 | ₹14.91 |
| EPS - Basic | ₹7.43 | ₹10.50 | ₹12.04 | ₹12.20 |
| EPS - Diluted | ₹7.43 | ₹10.50 | ₹12.04 | ₹12.20 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹9.45 | ₹13.30 | ₹15.00 | ₹14.91 |
| Income before WC changes | ₹22.28 | ₹27.56 | ₹25.90 | ₹25.14 |
| Change in Assets | -₹12.84 | -₹17.14 | -₹34.31 | -₹25.97 |
| Change in Liabilities | -₹10.73 | -₹7.60 | ₹1.79 | ₹8.84 |
| Change in WC | -₹23.57 | -₹24.74 | -₹32.52 | -₹17.13 |
| Cash flow from Operations | -₹2.63 | -₹0.25 | -₹3.50 | ₹4.81 |
| Cash flow from Investing | -₹1.72 | -₹8.71 | -₹7.54 | -₹8.47 |
| Cash flow from Financing | -₹6.68 | ₹3.14 | ₹27.67 | ₹4.39 |
| Total Cash Flow | -₹11.04 | -₹5.82 | ₹16.63 | ₹0.73 |
| Cash (Start of the year) | ₹14.62 | ₹20.44 | ₹3.81 | ₹3.08 |
| Cash (End of the year) | ₹3.58 | ₹14.62 | ₹20.44 | ₹3.81 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹139.68 | ₹141.84 | ₹118.81 | ₹104.72 |
| Current Assets | ₹153.51 | ₹152.37 | ₹157.97 | ₹120.98 |
| Total Assets | ₹293.19 | ₹294.21 | ₹276.78 | ₹225.70 |
| Current Liabilities | ₹72.58 | ₹82.30 | ₹80.46 | ₹71.13 |
| Net Current Asset | ₹80.93 | ₹70.07 | ₹77.51 | ₹49.85 |
| Non-Current Liabilities | ₹2.97 | ₹2.71 | ₹2.53 | ₹6.53 |
| Equity Capital | ₹217.64 | ₹209.21 | ₹193.80 | ₹148.04 |
| Total Equity & Liabilities | ₹293.19 | ₹294.21 | ₹276.78 | ₹225.70 |
About Medicamen Biotech
Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider. The Company is principally engaged in generic finished dosage forms (FDF), Oncology formulations and research and development services to cater to the needs of the global pharmaceutical industry. The Company’s focus areas include antibiotics, hypertension, general pain management, cardiovascular, diabetics and oncology formulations. In cardiology, the Company is delivering effective treatments for heart-related conditions. Its CNS products address neurological disorders, while its diabetology solutions focus on advanced diabetes management. It also contributes to the global fight against malaria with its anti-malarial medications. Additionally, the Company offers essential vitamins, antibiotics for bacterial infections, and comprehensive pain management solutions. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, and others.
Medicamen Biotech Financial Highlights
- Revenue: Medicamen Biotech reported revenue of ₹200.88 crore in FY26 vs ₹168.79 crore in FY25. It showed an increase of 19.01% on a yearly basis.
- Operating Profit: Medicamen Biotech reported an operating profit of ₹11.98 crore in FY26 vs ₹9.88 crore in FY25. It showed an increase of 21.26% on a year-on-year basis.
- Net Profit: Medicamen Biotech reported a net profit of ₹9.80 crore in FY26 vs ₹6.56 crore in FY25. It showed an increase of 49.39% on a yearly basis.
Medicamen Biotech Quarterly Result Highlights
- Medicamen Biotech reported revenue of ₹62.39 crore in Mar 2026, compared with ₹47.44 crore in Dec 2025, representing an increase of 31.51% on a quarter-on-quarter (QoQ) basis.
- Medicamen Biotech reported an operating profit of ₹5.06 crore in Mar 2026, compared with ₹2.11 crore in Dec 2025, representing an increase of 139.81% on a quarter-on-quarter (QoQ) basis.
- Medicamen Biotech reported a profit of ₹4.45 crore in Mar 2026, compared with ₹1.63 crore in Dec 2025, reflecting an increase of 173.01% on a QoQ basis.
- The earnings per share (EPS) of Medicamen Biotech stood at ₹5.60 during Mar 2026.
Similar Stocks
FAQs on Medicamen Biotech Share Price
What is Medicamen Biotech share price today?
Medicamen Biotech share price is ₹260.05 as on 06 Jul, 2026, 13:37 IST.
How has the Medicamen Biotech share price performed in the past?
In the last 1 year, Medicamen Biotech delivered a return of -35.80%. The Medicamen Biotech share price hit a high of ₹447.65 and low of ₹212.40.
How much is the Mutual Fund shareholding in Medicamen Biotech shares?
The Mutual Fund Shareholding in Medicamen Biotech was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Medicamen Biotech shares ?
The 52-week high and low of Medicamen Biotech share is ₹447.65 and ₹212.40 as of 06 Jul, 2026.
What is the market cap of Medicamen Biotech?
The market capitalisation of Medicamen Biotech is ₹349.79 Crores as on 06 Jul, 2026.
What are the stock symbols of Medicamen Biotech?
The stock symbol of Medicamen Biotech is MEDICAMEQ on the NSE, 531146 on the BSE, and the ISIN is INE646B01010.
What was yesterday's closing price of Medicamen Biotech shares ?
Medicamen Biotech shares closed yesterday at ₹260.90 on NSE & ₹262.00 on BSE
How to buy Medicamen Biotech shares?
To buy Medicamen Biotech shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Medicamen Biotech shares on Holidays?
No, shares of Medicamen Biotech or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Medicamen Biotech shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Medicamen Biotech?
The PE and PB ratio of Medicamen Biotech is 35.72 and 1.27 respectively, as on 06 Jul, 2026, 13:37 IST.